CDTX - Cidara Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$177.88
DETAILS
HIGH:
$221.50
LOW:
$150.00
MEDIAN:
$170.00
CONSENSUS:
$177.88
DOWNSIDE:
19.65%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -13811.9% |
| EBITDA Margin | -13793.6% |
| Operating Margin | -13811.9% |
| Pretax Margin | -13356.2% |
| Cont. Ops Margin | -13356.2% |
| Net Margin | -13319.8% |
| Bottom Line Margin | -13319.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.25 |
| Quick Ratio | 4.25 |
| Solvency Ratio | -3.294 |
| Cash Ratio | 3.83 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.01
Peers avg: 12.2
|
| PEG Ratio | -0.00 |
| Forward PEG | -0.00 |
| Price/Book | 1.05 |
| Price/Sales | 133.87 |
| Price/FCF | -0.97 |
| Price/Op Cash Flow | -0.97 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0166 |
| Debt/Equity | 0.0219 |
| Debt/Capital | 0.0214 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.32 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.02 |
| Operating Cash Flow Ratio | -3.562 |
| Operating Cash Flow/Sales | -13845.7% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -49.37 |
| Capital Expenditure Coverage | -1368.47 |
| Dividend + Capital Expenditure Coverage | -1368.47 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.20 |
| EPS | -26.746 |
| Debt/Share | 0.5632 |
| Cash/Share | 29.90 |
| Book Value/Share | 25.72 |
| Tangible BV/Share | 25.72 |
| Equity/Share | 25.72 |
| Operating Cash Flow/Share | -27.802 |
| Capital Expenditure/Share | 0.020 |
| FCF/Share | -27.822 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.997 |
| Earnings Before Tax/EBIT | 0.967 |
| Price/Fair Value | 1.05 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | 0.09 |